• Expertise
  • Ingredient Solutions
  • Applications
  • Resources
    Resources
  • PLT People & Planet
  • About
    About

    Our international network, passionate team of experts and extensive industry knowledge is what sets us apart.

    Seth circle headshot
    Seth Flowerman
    President and CEO
Press Releases

PLT Health Solutions Launches New Ingredient for 
Men’s Sexual Health

October 21, 2024

Morristown, NJ 21 October 2024 – PLT Health Solutions today announced the launch of TestFACTOR® Sexual Wellness & Longevity, a groundbreaking new sexual health ingredient for global markets. Comprising two standardized botanical extracts with a rich Ayurvedic history— East Indian Globe Thistle (Spaeranthus indicus) and Mango Tree Bark (Mangifera indica)–this innovative and multi-patented ingredient has been shown to increase both Free and Total Testosterone in men across four randomized, double-blind, placebo-controlled clinical studies. The most recent study, focusing on sexual health and performance, demonstrated that TestFACTOR significantly enhances overall sexual function, including improvements in desire, frequency, pleasure and other key factors. The study also demonstrated that TestFACTOR reduced mental and physical fatigue and improved grip strength.*

 

Seth Flowerman, President & CEO of PLT Health Solutions, highlighted the rising interest among men in maintaining healthy testosterone levels. "Men are becoming increasingly aware of testosterone’s pivotal role in overall health—with benefits spanning sexual wellness to physical strength, endurance, and muscle mass," said Flowerman. "The unique combination of extracts in TestFACTOR has demonstrated impressive results across four clinical trials and has been shown to boost both Free and Total Testosterone. We are proud that our customers are featuring it in a growing range of leading men's health formulations."

 

A novel ingredient with broad ranging benefits

In the most recent clinical study assessing men’s sexual health, sixty healthy, non-obese, recreationally active men took either 325 mg/day TestFACTOR or a matching placebo for eight weeks. Key outcome measures included biomarkers for testosterone (Total and Free), dihydrotestosterone (DHT), and testosterone-to-estradiol ratio. Questionnaires included a Change in Sexual Function Questionnaire (CSFQ), the Chalder Fatigue Scale (CFQ), Perceived Stress Scale (PSS), the Athens Insomnia Scale (AIS) and the SF-36 vitality scale. Physical assessments included grip strength and body composition (DEXA).

 

By eight weeks, subjects taking TestFACTOR saw a 19% increase in Total Testosterone and a 20% increase in Free Testosterone compared to baseline values. Overall improvement in sexual function was 48%. Sexual frequency was improved by 58%, sexual interest by 45%, erections by 49%, and pleasure by 44%. TestFACTOR subjects had lower scores for both mental and physical fatigue. Grip strength, an important marker of longevity, was improved by 14.5% for TestFACTOR subjects. All of these outcomes were statistically significant versus placebo.*

According to Jennifer Murphy, MS, RD, Director of Innovation & Clinical Development for PLT Health Solutions, the most recent clinical trial on TestFACTOR was developed based on the ingredient’s previously demonstrated support for testosterone enhancement. “We understood the impacts on testosterone from the prior clinical work, which focused on strength. We wanted to focus this study on understanding the potential benefits to men’s sexual health,” she said. “We saw that TestFACTOR offers a significant opportunity for men to improve their sexual function and enhance their experience, improve energy, and support their long-term vitality,” she added.

 

For more information on TestFACTOR Sexual Wellness & Longevity, visit: www.plthealth.com/testfactor.

*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.